Bharat Biotech to conduct Phase-3 trials of Covaxin

BharatBiotech,which is into developing Covaxin, a vaccine candidate for Covid-19, on Friday said it has successfully completed interim analysis of Phase I and II trials and is initiating Phase-III trials in 26,000 participants. Covaxin is being developed byBharatBiotech in collaboration with the Indian Council of Medical Research- National Institute of Virology.